BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $448,766 | -10.6% | 9,850 | 0.0% | 0.27% | -24.3% |
Q4 2022 | $502,055 | -5.5% | 9,850 | 0.0% | 0.36% | -13.2% |
Q3 2022 | $531,000 | -16.1% | 9,850 | 0.0% | 0.42% | -10.7% |
Q2 2022 | $633,000 | -25.2% | 9,850 | 0.0% | 0.47% | -7.2% |
Q4 2021 | $846,000 | +6.8% | 9,850 | 0.0% | 0.50% | -2.9% |
Q3 2021 | $792,000 | -0.1% | 9,850 | 0.0% | 0.52% | -0.2% |
Q2 2021 | $793,000 | -4.6% | 9,850 | 0.0% | 0.52% | -10.8% |
Q1 2021 | $831,000 | +4.9% | 9,850 | 0.0% | 0.58% | -8.1% |
Q3 2020 | $792,000 | -1.0% | 9,850 | 0.0% | 0.63% | -23.8% |
Q1 2020 | $800,000 | -2.9% | 9,850 | 0.0% | 0.83% | +16.9% |
Q4 2019 | $824,000 | -4.4% | 9,850 | 0.0% | 0.71% | -10.7% |
Q3 2019 | $862,000 | +6.8% | 9,850 | 0.0% | 0.80% | +12.0% |
Q2 2019 | $807,000 | +0.7% | 9,850 | 0.0% | 0.71% | -1.0% |
Q1 2019 | $801,000 | +23.6% | 9,850 | 0.0% | 0.72% | +9.1% |
Q4 2018 | $648,000 | -14.6% | 9,850 | 0.0% | 0.66% | -1.5% |
Q3 2018 | $759,000 | +4.4% | 9,850 | 0.0% | 0.67% | +0.5% |
Q2 2018 | $727,000 | +13.4% | 9,850 | 0.0% | 0.66% | +13.7% |
Q1 2018 | $641,000 | +0.6% | 9,850 | 0.0% | 0.58% | +0.9% |
Q4 2017 | $637,000 | – | 9,850 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |